These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36989173)

  • 21. The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study.
    Purssell H; Bennett L; Street O; Hanley KP; Hanley N; Vasant DH; Athwal VS
    Sci Rep; 2023 May; 13(1):8769. PubMed ID: 37253969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and associated factors of disorders of gut-brain interaction in the United States: Comparison of two nationwide Internet surveys.
    Palsson OS; Sperber AD; Bangdiwala S; Whitehead WE
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14564. PubMed ID: 36961084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global prevalence and burden of meal-related abdominal pain.
    Colomier E; Melchior C; Algera JP; Hreinsson JP; Störsrud S; Törnblom H; Van Oudenhove L; Palsson OS; Bangdiwala SI; Sperber AD; Tack J; Simrén M
    BMC Med; 2022 Feb; 20(1):71. PubMed ID: 35172840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and impact of disorders of Gut-Brain interaction in Sweden.
    Tornkvist NT; Simrén M; Hreinsson JP; Tack J; Bangdiwala SI; Sperber AD; Palsson OS; Josefsson A; Törnblom H
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14578. PubMed ID: 37018426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups.
    Hreinsson JP; Törnblom H; Tack J; Drossman DA; Whitehead WE; Bangdiwala SI; Sperber AD; Palsson OS; Simrén M
    Gastroenterology; 2023 Jun; 164(7):1211-1222. PubMed ID: 36889555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar.
    Kovács DB; Szekely A; Hubai AG; Palsson O
    BMJ Open Gastroenterol; 2022 Aug; 9(1):. PubMed ID: 35953148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.
    Aziz I; Palsson OS; Törnblom H; Sperber AD; Whitehead WE; Simrén M
    Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):252-262. PubMed ID: 29396034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.
    Sperber AD; Bangdiwala SI; Drossman DA; Ghoshal UC; Simren M; Tack J; Whitehead WE; Dumitrascu DL; Fang X; Fukudo S; Kellow J; Okeke E; Quigley EMM; Schmulson M; Whorwell P; Archampong T; Adibi P; Andresen V; Benninga MA; Bonaz B; Bor S; Fernandez LB; Choi SC; Corazziari ES; Francisconi C; Hani A; Lazebnik L; Lee YY; Mulak A; Rahman MM; Santos J; Setshedi M; Syam AF; Vanner S; Wong RK; Lopez-Colombo A; Costa V; Dickman R; Kanazawa M; Keshteli AH; Khatun R; Maleki I; Poitras P; Pratap N; Stefanyuk O; Thomson S; Zeevenhooven J; Palsson OS
    Gastroenterology; 2021 Jan; 160(1):99-114.e3. PubMed ID: 32294476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Face-to-face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population-based research.
    Sperber AD; Bor S; Fang X; Bangdiwala SI; Drossman DA; Ghoshal UC; Simren M; Tack J; Whitehead WE; Dumitrascu DL; Fukudo S; Kellow J; Okeke E; Quigley EMM; Schmulson M; Whorwell P; Archampong T; Adibi P; Andresen V; Benninga MA; Bonaz B; Fernandez LB; Choi SC; Corazziari ES; Francisconi C; Hani A; Lazebnik L; Lee YY; Mulak A; Rahman MM; Santos J; Setshedi M; Syam AF; Vanner S; Wong RK; Lopez-Colombo A; Costa V; Dickman R; Kanazawa M; Keshteli AH; Khatun R; Maleki I; Poitras P; Pratap N; Stefanyuk O; Thomson S; Buyruk M; Unal N; Huang D; Song J; Hreinsson JP; Palsson OS
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14583. PubMed ID: 37018412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global patterns of prescription pain medication usage in disorders of gut-brain interactions.
    Luo Y; Camey SA; Bangdiwala SI; Palsson OS; Sperber AD; Keefer LA
    Neurogastroenterol Motil; 2023 Jan; 35(1):e14457. PubMed ID: 36111642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global Prevalence of Psychological Distress and Comorbidity With Disorders of Gut-Brain Interactions.
    Trindade IA; Hreinsson JP; Melchior C; Algera JP; Colomier E; Törnblom H; Drossman D; Tack J; Palsson OS; Bangdiwala SI; Sperber AD; Simrén M
    Am J Gastroenterol; 2024 Jan; 119(1):165-175. PubMed ID: 37721510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Worldwide population prevalence and impact of sub-diagnostic gastrointestinal symptoms.
    Palsson OS; Tack J; Drossman DA; Le Nevé B; Quinquis L; Hassouna R; Ruddy J; Morris CB; Sperber AD; Bangdiwala SI; Simrén M
    Aliment Pharmacol Ther; 2024 Apr; 59(7):852-864. PubMed ID: 38311841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The aging gastrointestinal tract: Epidemiology and clinical significance of disorders of gut-brain interaction in the older general population.
    Sperber AD; Freud T; Palsson OS; Bangdiwala SI; Simren M
    Aliment Pharmacol Ther; 2024 Aug; 60(4):446-456. PubMed ID: 38837277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Associated Factors of Bloating: Results From the Rome Foundation Global Epidemiology Study.
    Ballou S; Singh P; Nee J; Rangan V; Iturrino J; Geeganage G; Löwe B; Bangdiwala SI; Palsson OS; Sperber AD; Lembo A; Lehmann M
    Gastroenterology; 2023 Sep; 165(3):647-655.e4. PubMed ID: 37315866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association among Disorders of Gut-Brain Interaction (DGBI) and Fibromyalgia: A Prospective Study.
    Settembre C; D'Antonio E; Moscato P; Loi G; Santonicola A; Iovino P
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: epidemiology of IBS and other bowel disorders of gut-brain interaction (DGBI).
    Sperber AD
    Aliment Pharmacol Ther; 2021 Dec; 54 Suppl 1():S1-S11. PubMed ID: 34927754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life measures in children with Down syndrome with disorders of gut-brain interaction.
    Ciciora SL; Manickam K; Saps M
    Am J Med Genet C Semin Med Genet; 2023 Dec; 193(4):e32071. PubMed ID: 37882146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
    Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut-brain interaction.
    Fairlie T; Shah A; Wong RK; Fang X; Ghoshal UC; Kashyap PC; Mulak A; Lee YY; Sperber AD; Koloski N; Moy N; Talley NJ; Jones MP; Holtmann G
    Neurogastroenterol Motil; 2024 Jul; ():e14866. PubMed ID: 39005136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pictograms to assess bloating and distension symptoms in the general population in Mexico: Results of The Rome Foundation Global Epidemiology Study.
    Schmulson MJ; López-Colombo A; Montiel Jarquin A; Puentes-Leal GA; Palsson OS; Bangdiwala SI; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14577. PubMed ID: 37010874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.